1000s of practice questions to help you prepare for the 2026 GPhC registration assessment, including extended matching answer, single best answer and calculations.
Breast cancer drug Enhertu recommended for NHS use
'Milestone victory belongs to every person who refused to accept that access to a life-extending treatment was out of reach'...
Insulin storage in neonatal units should be digitally restricted, inquiry says
Thirlwell recommendations include the use of devices to record unit access....
Push for progress: what the rare diseases framework extension means for patients and the future of UK innovation
The development represents a test of whether rare disease policy can be fully integrated into the health systems transformation agenda....
MHRA reviewing risks and safeguards for propranolol use in anxiety
Medicines safety working group raise concerns that poisoning from the beta blocker 'results in a significant number of deaths'....
GLP-1s: what is behind the variation in efficacy?
Researchers are trying to untangle the roles of genetics, access and treatment persistence in the efficacy of GLP-1s. As evidence...
NHS England to review guidance for pain management in ketamine users following patient death
The Dorset coroner expressed concern that there were no prescribing guidelines for analgesia in patients with ketamine bladder syndrome who...
Published by The Royal College of Pharmacy
66-68 East Smithfield
London
E1W 1AW
VAT number: 513 9738 73
A charity registered in England and Wales (1217916), and Scotland (SC055605)
